Interestingly, TNFα inhibition has been shown to reduce generation of monomeric Aβ in a murine model of AD [21] and TNFα inhibitors produce sustained clinical improvement in patients with AD [22]. The gene discussed is TNF; the disease is Alzheimer disease.